Tctc Holdings, LLC Amgen Inc Transaction History

Tctc Holdings, LLC

$2.88 Billion
Q3 2024

A detailed history of Tctc Holdings, LLC transactions in Amgen Inc stock. As of the latest transaction made, Tctc Holdings, LLC holds 34,173 shares of AMGN stock, worth $9.57 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

34,173

Previous 35,074 2.57%

Holding current value

$9.57 Million

Previous $11 Million 0.47%

% of portfolio

0.38%

Previous 0.39%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$309.38 - $337.38 $278,751 - $303,979	-901 Reduced 2.57%	34,173 $11 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $158,438 - $192,543	-603 Reduced 1.69%	35,074 $11 Million
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $18,014 - $21,745	-67 Reduced 0.19%	35,677 $10.1 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $473,812 - $534,516	-1,853 Reduced 4.93%	35,744 $10.3 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $74,341 - $92,296	-340 Reduced 0.9%	37,597 $10.1 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $404,970 - $478,869	-1,890 Reduced 4.75%	37,937 $8.42 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $141,118 - $172,000	-625 Reduced 1.55%	39,827 $9.63 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $1.15 Million - $1.46 Million	-5,018 Reduced 11.04%	40,452 $10.6 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $65,093 - $73,413	-290 Reduced 0.63%	45,470 $10.2 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $87,439 - $97,304	-379 Reduced 0.82%	45,760 $11.1 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $73,455 - $81,260	-335 Reduced 0.72%	46,139 $11.2 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $1.17 Million - $1.34 Million	5,900 Added 14.54%	46,474 $10.5 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $84,908 - $99,480	-400 Reduced 0.98%	40,574 $8.63 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $5,605 - $6,219	24 Added 0.06%	40,974 $9.99 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $71,676 - $83,527	323 Added 0.8%	40,950 $10.2 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $175,700 - $209,228	812 Added 2.04%	40,627 $9.34 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $93,390 - $103,858	-398 Reduced 0.99%	39,815 $10.1 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $416,587 - $511,210	-2,106 Reduced 4.98%	40,213 $9.49 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $518,655 - $687,878	2,846 Added 7.21%	42,319 $8.58 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $87,982 - $113,088	-465 Reduced 1.16%	39,473 $9.52 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $184,556 - $221,137	-1,060 Reduced 2.59%	39,938 $7.73 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $432,919 - $507,479	2,597 Added 6.76%	40,998 $7.56 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $25,321 - $28,543	140 Added 0.37%	38,401 $7.3 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $27,652 - $32,278	-155 Reduced 0.4%	38,261 $7.45 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $73,745 - $83,138	-398 Reduced 1.03%	38,416 $7.96 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $137,987 - $154,989	831 Added 2.19%	38,814 $7.17 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $87,256 - $101,970	515 Added 1.37%	37,983 $6.48 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $55,869 - $62,423	-331 Reduced 0.88%	37,468 $6.52 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $76,116 - $86,905	-455 Reduced 1.19%	37,799 $7.05 Million
Q2 2017 Aug 14, 2017	BUY	N/A	38,254	38,254 $6.59 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tctc Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tctc Holdings, LLC with notifications on news.

Account

Tctc Holdings, LLC Amgen Inc Transaction History